DSP and colorectal carcinoma: Here, we employed two separate mouse models of CRC with various activin signaling pathway disruptions and performed and DSP analysis on several stage II/III CRC patient samples from the QUASAR II cohort to identify cellular signatures relative to activin co-localization in the TME.